Effects of a Mobile Game in Menopausal Women
The Effects of Mobile Gaming on Brain Fog and Psychological Well-Being Among Menopausal Women
1 other identifier
interventional
82
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effect of a mobile game-based cognitive intervention on brain fog and psychological well-being in menopausal women aged 45-55 years. The main questions it aims to answer are: Are Brain Fog Scale scores lower among women in the mobile game intervention group compared with women in the control group? Are Warwick-Edinburgh Mental Well-Being Scale scores higher among women in the mobile game intervention group compared with women in the control group? Do women participating in the mobile game intervention demonstrate greater reductions in Brain Fog Scale scores and greater improvements in Warwick-Edinburgh Mental Well-Being Scale scores after the intervention compared with their baseline measurements? Researchers will compare participants receiving the mobile game-based cognitive intervention with participants receiving routine follow-up only to determine the effectiveness of the intervention on brain fog and psychological well-being. Participants will: Complete baseline assessments using the Brain Fog Scale and the Warwick-Edinburgh Mental Well-Being Scale. Be randomly assigned to either the intervention group or the control group. Use the cognitive training mobile game for 15 minutes per day, 5 days per week, for 6 weeks if assigned to the intervention group. Receive routine follow-up only if assigned to the control group. Complete post-intervention assessments at the end of the 6-week study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedStudy Start
First participant enrolled
October 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2027
Study Completion
Last participant's last visit for all outcomes
December 15, 2027
September 17, 2026
August 1, 2026
11 months
August 30, 2026
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain fog
Change in Brain Fog Scale total score from baseline to post-intervention. The Brain Fog Scale is a 30-item instrument assessing cognitive, physical, and psychological symptoms of brain fog. Total scores range from 30 to 150, with higher scores indicating greater brain fog severity (worse outcome).
Baseline and Week 6
Secondary Outcomes (1)
Change in Warwick-Edinburgh Mental Well-Being
Baseline and Week 6
Study Arms (2)
Menopause Mobile Game Intervention
EXPERIMENTALParticipants will use a mobile game developed to address brain fog symptoms during menopause.
Routine Care Control
NO INTERVENTIONParticipants will receive routine care and will not use the mobile game during the study period.
Interventions
Participants in the intervention group will use a mobile game specifically designed for menopausal women to support cognitive functioning. The game includes interactive exercises and activities targeting attention, memory, processing speed, and other cognitive skills. Participants will use the mobile game throughout the intervention period in addition to routine care.
Eligibility Criteria
You may qualify if:
- Women aged 45-55 years
- Able to read and write in Turkish
- Able to use a smartphone (Android or iOS)
- Amenorrhea for at least 12 months
- Willing to participate and provide written informed consent
You may not qualify if:
- Diagnosis of serious neurological disorders such as dementia, Alzheimer's disease, epilepsy, or multiple sclerosis
- Diagnosis of severe psychiatric disorders such as major depression, bipolar disorder, or schizophrenia
- Regular use of medications that may significantly affect cognitive function, including antiepileptics, antiparkinsonian drugs, antipsychotics, or antidepressants
- Participation in cognitive training, memory training, or a similar digital intervention within the last 6 months
- Visual, auditory, or motor impairments that would prevent the use of the mobile application
- Participants scoring within the lowest 25% quartile (Q1) on the Brain Fog Scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medipol Universitylead
- Istanbul University - Cerrahpasacollaborator
Study Sites (1)
İstanbul Medipol University Mega Hospital
Istanbul, Mrs, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nazire BAHAR
Istanbul Universitesi-Cerrahpasa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 30, 2026
First Posted
September 2, 2026
Study Start (Estimated)
October 15, 2026
Primary Completion (Estimated)
September 15, 2027
Study Completion (Estimated)
December 15, 2027
Last Updated
September 17, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared because the study involves sensitive health-related information collected from participants. Data will be used solely for the purposes of this research and will be reported in aggregate form to protect participant confidentiality.